RNeasy Mini Kit

High-quality total RNA in minutes.

Investigator 24plex QS Kit

Multiplex amplification for human ID, with CODIS and European standard markers.

QIAsphere

Monitor and manage your QIAsphere-ready instruments from anywhere, using any mobile device.

Smart ideas, deep insights

Get inspiring content today – with a free face mask.

QIAGEN Clinical Insight (QCI) Interpret

Transparent, evidence-based NGS interpretation and reporting.

Find out more

QIAGENbioinformatics.com

COVID-19 testing and research

Up to date protocols and list of COVID-19 testing and research solutions.

RNeasy Mini Kit

High-quality total RNA in minutes.

Smart ideas, deep insights

Get inspiring content today – with a free face mask.

QuantiFERON-TB Gold Plus

Detect TB infection with confidence.

QIAGEN Clinical Insight (QCI) Interpret

Transparent, evidence-based NGS interpretation and reporting.

Analyst Consensus

Home  >  Investor Relations  >  Stock Information  >  Analyst Consensus

Disclaimer

QIAGEN N.V. is covered by various financial analysts and has contracted Vara Research to periodically update the consensus analysis, based on the estimates of all participating brokerage firms. The most recent analyst consensus is given below. Any opinions, forecasts, estimates, projections or predictions regarding QIAGEN’s performance made by the analysts (and, therefore, the consensus estimate numbers) are theirs alone and do not represent the opinions, forecasts, estimates, projections or predictions of QIAGEN or its management.

QIAGEN does not by providing these estimates imply, and expressly disclaims, any endorsement of or concurrence with any information, estimates, forecasts, opinions, conclusions or recommendations made or provided by Vara Research or such analysts. QIAGEN assumes no liability for the accuracy of such estimates and undertakes no obligation to update or revise such estimates.